Alemtuzumab Consolidation Does Not Improve Outcome for CLL Patients with High Risk Genomic Features on Successive CALGB Trials
- Citation:
- Blood vol 118 (21) -1791
- Meeting Instance:
- ASH 2011
- Year:
- 2011
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Comprehensive
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 1018
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- J. A. Jones A. Stark W. Zhao T. S. Lin K. R. Rai G. Marcucci B. Peterson R. A. Larson N. A. Heerema J. C. Byrd
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-10101, CALGB-19901
- Phases:
- 2
- Keywords: